If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRM2.L Regulatory News (RM2)

  • There is currently no data for RM2

Director / PDMR Shareholding

14 Apr 2014 16:19

RNS Number : 8009E
RM2 International SA
14 April 2014
Β 

ο»Ώ

RM2 International S.A.

Β 

Director / PDMR Shareholding

Β 

RM2 International S.A. ("RM2" or the "Company") announces that it was today notified that Jan Dekker, a Non-Executive Director of RM2, purchased a total of 176,000 ordinary shares in the Company ("Ordinary Shares") on 11 and 14 April 2014 at a price of 70 pence per Ordinary Share.

Β 

Following this transaction, Mr Dekker is interested in a total of 2,300,000 Ordinary Shares, representing approximately 0.72 per cent. of the existing issued share capital of the Company.

Β 

For further information please contact:

Β 

RM2 International S.A.Β 

John Walsh, Chief Executive Officer

Ash Mohindra, Chief Financial Officer

Ruari McGirr, Strategic Development and Investor Relations

+44 (0)20 8820 1412

Β 

Β 

Cenkos Securities plc

Neil McDonaldΒ 

Alan Stewart

Beth McKiernan

+44 (0)20 7397 8900

Β 

Β 

Citigate Dewe Rogerson

Simon Rigby

Kevin Smith

Lindsay Noton

+44 (0)20 7638 9571

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSGGUMGCUPCGAC
Date   Source Headline
1st Jun 20181:13 pmRNSResult of AGM
21st May 20187:00 amRNSLaunch of Open Offer
21st May 20187:00 amRNS2017 Annual Results
1st May 20187:00 amRNSManufacturing operations update
23rd Apr 201812:55 pmRNSIssue of Shares to Directors
19th Apr 20182:05 pmRNSSecond Price Monitoring Extn
19th Apr 20182:00 pmRNSPrice Monitoring Extension
13th Apr 20184:40 pmRNSSecond Price Monitoring Extn
13th Apr 20184:35 pmRNSPrice Monitoring Extension
13th Apr 20181:33 pmRNSResults of EGM and Trading Update
29th Mar 20187:00 amRNSPlacing, Pref. Share Conversion and Notice of EGM
29th Mar 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSDirectorate Change
20th Mar 20184:40 pmRNSSecond Price Monitoring Extn
20th Mar 20184:35 pmRNSPrice Monitoring Extension
9th Mar 20187:00 amRNSFinancial Position and Product Update
12th Feb 20187:00 amRNSFinancial Position Update
19th Jan 20187:00 amRNSFinancial Position Update
13th Dec 201711:00 amRNSPrice Monitoring Extension
1st Dec 20177:00 amRNSUpdate on Trading and Financial Position
1st Nov 20177:00 amRNSChange of Broker
27th Sep 20177:00 amRNSInterim Results
24th Aug 20177:00 amRNSBoard Appointment and Increase in Treasury Shares
3rd Aug 20177:00 amRNSBoard and Management Changes
28th Jul 20172:47 pmRNSResult of AGM
24th Jul 20171:49 pmRNSProposed Equity Offering Update
11th Jul 20178:23 amRNSAward of Restricted Shares and Options
6th Jul 20177:00 amRNSNotice of EGM
30th Jun 20174:10 pmRNSSubscription for Convertible Preferred Shares
30th Jun 20173:42 pmRNSAppointment of CEO
30th Jun 20173:41 pmRNSAnnual Results 2016
9th Mar 20178:00 amRNSRM2 Wins First Place for IoT Award for Innovation
20th Feb 201710:22 amRNSEGM Resolutions Passed
20th Feb 20177:00 amRNSDirector/PDMR Shareholding
15th Feb 20178:22 amRNSAT&T LTE-M network deployment
6th Feb 20177:00 amRNSNotice of EGM
2nd Feb 20177:00 amRNSRM2 Product Approved by Major US Retailer
22nd Dec 20167:00 amRNSManufacturing operations update
4th Nov 201610:46 amRNSRM2 to Participate in the AT&T
4th Nov 20168:53 amRNSAgreement with Pactiv LLC
2nd Nov 20167:00 amRNSAgreement with Pactiv LLC
1st Nov 20167:00 amRNSPallet Loss Will Be Reduced with RM2 Innovation
20th Oct 20168:25 amRNSNominated Adviser & Joint Broker Appointments
13th Oct 20167:00 amRNSSignificant new agreement
28th Sep 20167:00 amRNSInterim Results
26th Sep 20167:00 amRNSRe Agreement
1st Aug 20162:14 pmRNSIssuance of Convertible Preferred Shares - Amended
29th Jul 20161:36 pmRNSIssuance of Convertible Preferred Shares
22nd Jul 20164:19 pmRNSEGM Resolutions Passed
18th Jul 201610:38 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.